ClinicalTrials.Veeva

Menu

Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women

Wyeth logo

Wyeth

Status and phase

Completed
Phase 1

Conditions

Vasomotor Symptoms

Treatments

Drug: desvenlafaxine succinate sustained release (DVS SR)

Study type

Interventional

Funder types

Industry

Identifiers

NCT00397176
3151A2-1200

Details and patient eligibility

About

Safety, tolerability, and pharmacokinetics (PK) of desvenlafaxine succinate sustained release (DVS SR) in healthy Japanese female subjects.

Sex

Female

Ages

20 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Healthy, first-generation (born in Japan, living in the US for less than 5 years)
  • Japanese female subjects

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems